Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Janis

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology|June 1, 1992
Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat heartsJ A Watts, S Chapat, D E Johnson, et al.
Biochemical Pharmacology|November 1, 1984
Interaction of phenoxybenzamine with muscarinic receptors and calcium channelsP J Gengo, F Yousif, R A Janis, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparationsM Gopalakrishnan, D E Johnson, R A Janis, et al.
Biochemical Pharmacology|October 15, 1984
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranesJ G Sarmiento, R A Janis, A M Katz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranesJ G Sarmiento, A V Shrikhande, R A Janis, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1993
Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine bindingD E Johnson, S L Heald, R D Dally, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
Biochemical and Biophysical Research Communications|January 29, 1993
High affinity binding of a potassium channel agonist to intact rat insulinoma cellsF J Hoffman, J B Lenfers, E Niemers, et al.
European Journal of Pharmacology|August 27, 1982
Binding of [3H]nimodipine to cardiac and smooth muscle membranesR A Janis, S C Maurer, J G Sarmiento, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1984
Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644R A Janis, J G Sarmiento, S C Maurer, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology|June 1, 1992
Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat heartsJ A Watts, S Chapat, D E Johnson, et al.
Biochemical Pharmacology|November 1, 1984
Interaction of phenoxybenzamine with muscarinic receptors and calcium channelsP J Gengo, F Yousif, R A Janis, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991
Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparationsM Gopalakrishnan, D E Johnson, R A Janis, et al.
Biochemical Pharmacology|October 15, 1984
Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranesJ G Sarmiento, R A Janis, A M Katz, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
[3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranesJ G Sarmiento, A V Shrikhande, R A Janis, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1993
Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine bindingD E Johnson, S L Heald, R D Dally, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1987
Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranesD Rampe, E Luchowski, A Rutledge, et al.
Biochemical and Biophysical Research Communications|January 29, 1993
High affinity binding of a potassium channel agonist to intact rat insulinoma cellsF J Hoffman, J B Lenfers, E Niemers, et al.
European Journal of Pharmacology|August 27, 1982
Binding of [3H]nimodipine to cardiac and smooth muscle membranesR A Janis, S C Maurer, J G Sarmiento, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1984
Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644R A Janis, J G Sarmiento, S C Maurer, et al.
Pageof 4